Diabetes Leader USV slashes price of its popular Diabetes Medicine JALRA OD - Video

Published On 2022-10-03T12:45:15+05:30 | Updated On 8 Dec 2022 12:08 PM IST

Overview

Mumbai: With an aim to make its popular antidiabetic medicine more affordable and accessible to the Indian population, leading pharma company USV Ltd. has now reduced the price of its brand Jalra-OD.

The once daily dosing tablet of JALRA OD which contains Vildagliptin 100mg SR will now be available at price of Rs 13.5 per tablet a sharp reduction from its earlier price of Rs 18 per tablet.

Jalra-OD is the No.1 prescribed brand as per data from healthplix and is trusted by more than 50 thousand patients. Jalra-OD which contains Vildagliptin 100mg SR is a well studied molecule with 90% DPP4 inhibition while the DPP4 inhibition by Sita 100mg is 86.9%. Along with being efficacious Vildagliptin 100mg SR has proven its hepatic and cardiac safety.

Reference: Herman GA, et al. Clinical Pharmacology & Therapeutics. 2005; 78(6):675-88.

Speakers

Dr. Nandita Mohan

BDS, MDS( Pedodontics and Preventive Dentistry)

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751